Cormorant Asset Management, LP Diversified Active

CIK: 0001583977 · Show all filings

Period: Q4 2014 (← Previous) (Next →)

Filing Date: Feb 17, 2015

Total Value ($000): $648,511 (100.0% shares, 0.0% debt)

Holdings (70)

RECEPTOS INC 12.1%
Value ($000) $78,627 Shares 641,800 Est. Cost $43.18 Unrealized
PBYI PUMA BIOTECHNOLOGY INC 6.4%
Value ($000) $41,639 Shares 220,000 Est. Cost $146.25 Unrealized +51.7%
CELGENE CORP 5.2%
Value ($000) $33,558 Shares 300,000 Est. Cost $111.86 Unrealized
OVASCIENCE INC 5.1%
Value ($000) $33,032 Shares 747,000 Est. Cost $25.13 Unrealized
ALKS ALKERMES PLC 4.1%
Value ($000) $26,352 Shares 450,000 Est. Cost $50.19 Unrealized +1.5%
NBIX NEUROCRINE BIOSCIENCES INC 3.4%
Value ($000) $22,340 Shares 1,000,000 Est. Cost $15.30 Unrealized +23.9%
DYAX CORP 3.3%
Value ($000) $21,090 Shares 1,500,000 Est. Cost $7.54 Unrealized
ARDX ARDELYX INC 3.1%
Value ($000) $19,901 Shares 1,053,500 Est. Cost $19.95 Unrealized +16.1%
QUOTIENT LTD 3.1%
Value ($000) $19,800 Shares 1,100,000 Est. Cost $13.62 Unrealized
REGULUS THERAPEUTICS INC 2.7%
Value ($000) $17,644 Shares 1,100,000 Est. Cost $14.62 Unrealized
SRNE SORRENTO THERAPEUTICS INC 2.7%
Value ($000) $17,623 Shares 1,750,000 Est. Cost $7.89 Unrealized -35.8%
PORTOLA PHARMACEUTICALS INC 2.6%
Value ($000) $16,992 Shares 600,000 Est. Cost $27.49 Unrealized
CHIMERIX INC 2.5%
Value ($000) $16,104 Shares 400,000 Est. Cost $27.07 Unrealized
BMY BRISTOL MYERS SQUIBB CO 2.3%
Value ($000) $14,758 Shares 250,000 Est. Cost $36.09 Unrealized +7.8%
KITE PHARMA INC 2.3%
Value ($000) $14,706 Shares 255,000 Est. Cost $46.23 Unrealized
OMER OMEROS CORP 2.2%
Value ($000) $14,429 Shares 582,300 Est. Cost $12.81 Unrealized +42.3%
KARYOPHARM THERAPEUTICS INC 2.2%
Value ($000) $14,411 Shares 385,000 Est. Cost $33.09 Unrealized
KERYX BIOPHARMACEUTICALS 2.2%
Value ($000) $14,150 Shares 1,000,000 Est. Cost $13.75 Unrealized
TESARO INC 1.7%
Value ($000) $11,157 Shares 300,000 Est. Cost $28.24 Unrealized
DXCM DEXCOM INC 1.7%
Value ($000) $11,010 Shares 200,000 Est. Cost $7.91 Unrealized +54.7%
ACCELERON PHARMA INC 1.5%
Value ($000) $9,740 Shares 250,000 Est. Cost $32.10 Unrealized
BCRX BIOCRYST PHARMACEUTICALS INC 1.5%
Value ($000) $9,728 Shares 800,000 Est. Cost $9.67 Unrealized +14.2%
SYNAGEVA BIOPHARMA CORP 1.4%
Value ($000) $9,279 Shares 100,000 Est. Cost $68.78 Unrealized
NOVAVAX INC 1.4%
Value ($000) $8,895 Shares 1,500,000 Est. Cost $4.95 Unrealized
SGMO SANGAMO BIOSCIENCES INC 1.2%
Value ($000) $7,605 Shares 500,000 Est. Cost $17.13 Unrealized -29.1%
ALDER BIOPHARMACEUTICALS INC 1.1%
Value ($000) $7,273 Shares 250,000 Est. Cost $23.68 Unrealized
HRTX HERON THERAPEUTICS INC 1.1%
Value ($000) $7,042 Shares 700,000 Est. Cost $11.95 Unrealized -31.7%
NEKTAR THERAPEUTICS 1.1%
Value ($000) $6,975 Shares 450,000 Est. Cost $12.07 Unrealized
ACELRX PHARMACEUTICALS INC 1.0%
Value ($000) $6,730 Shares 1,000,000 Est. Cost $9.56 Unrealized
ADVAXIS INC 1.0%
Value ($000) $6,724 Shares 839,500 Est. Cost $6.07 Unrealized
APTOSE BIOSCIENCES INC 1.0%
Value ($000) $6,404 Shares 1,083,333 Est. Cost $5.91 Unrealized
EGRX EAGLE PHARMACEUTICALS INC 1.0%
Value ($000) $6,200 Shares 400,000 Est. Cost $13.58 Unrealized -5.9%
CHINA BIOLOGIC PRODS INC 0.9%
Value ($000) $6,051 Shares 90,000 Est. Cost $44.47 Unrealized
RARE ULTRAGENYX PHARMACEUTICAL INC 0.8%
Value ($000) $5,266 Shares 120,000 Est. Cost $46.32 Unrealized -1.1%
AUSPEX PHARMACEUTICALS INC 0.8%
Value ($000) $5,248 Shares 100,000 Est. Cost $30.76 Unrealized
ARRAY BIOPHARMA INC 0.7%
Value ($000) $4,730 Shares 1,000,000 Est. Cost $5.01 Unrealized
VERSARTIS INC 0.7%
Value ($000) $4,490 Shares 200,000 Est. Cost $28.04 Unrealized
IMMUNE DESIGN CORP 0.7%
Value ($000) $4,309 Shares 140,000 Est. Cost $17.66 Unrealized
NANOSTRING TECHNOLOGIES INC 0.6%
Value ($000) $4,179 Shares 300,000 Est. Cost $20.65 Unrealized
ROCKWELL MED INC 0.6%
Value ($000) $4,112 Shares 400,000 Est. Cost $12.66 Unrealized
BRISTOL MYERS SQUIBB CO 0.6%
Value ($000) $3,700 Shares 5,000 Est. Cost $197.00 Unrealized
CHRS COHERUS BIOSCIENCES INC 0.6%
Value ($000) $3,626 Shares 222,200 Est. Cost $14.11 Unrealized 0.0%
DERMIRA INC 0.6%
Value ($000) $3,622 Shares 200,000 Est. Cost $18.11 Unrealized
AVALANCHE BIOTECHNOLOGIES IN 0.5%
Value ($000) $3,510 Shares 65,000 Est. Cost $34.18 Unrealized
LIPOCINE INC NEW 0.5%
Value ($000) $3,507 Shares 666,666 Est. Cost $5.26 Unrealized
GLYCOMIMETICS INC 0.5%
Value ($000) $3,401 Shares 472,300 Est. Cost $16.33 Unrealized
DICERNA PHARMACEUTICALS INC 0.5%
Value ($000) $3,294 Shares 200,000 Est. Cost $16.47 Unrealized
AGENUS INC 0.5%
Value ($000) $3,176 Shares 800,000 Est. Cost $3.32 Unrealized
FORWARD PHARMA A/S-ADR 0.5%
Value ($000) $3,125 Shares 150,000 Est. Cost $20.83 Unrealized
CERULEAN PHARMA INC 0.4%
Value ($000) $2,799 Shares 450,000 Est. Cost $5.80 Unrealized
GENVEC INC 0.4%
Value ($000) $2,765 Shares 1,329,300 Est. Cost $2.65 Unrealized
KINDRED BIOSCIENCES INC 0.4%
Value ($000) $2,608 Shares 350,000 Est. Cost $11.93 Unrealized
AQUINOX PHARMACEUTICALS INC 0.3%
Value ($000) $2,250 Shares 300,000 Est. Cost $12.15 Unrealized
RECRO PHARMA INC 0.3%
Value ($000) $2,002 Shares 700,000 Est. Cost $6.07 Unrealized
CELLECTAR BIOSCIENCES INC 0.3%
Value ($000) $1,638 Shares 530,000 Est. Cost $2.22 Unrealized
CELSUS THERAPEUTICS PLC 0.2%
Value ($000) $1,440 Shares 300,000 Est. Cost $5.99 Unrealized
BELLICUM PHARMACEUTICALS INC 0.2%
Value ($000) $1,382 Shares 60,000 Est. Cost $23.03 Unrealized
AKBA AKEBIA THERAPEUTICS INC 0.2%
Value ($000) $1,374 Shares 118,000 Est. Cost $24.08 Unrealized -40.4%
APPLIED GENETIC TECHNOL CORP 0.2%
Value ($000) $1,274 Shares 60,600 Est. Cost $23.10 Unrealized
GALT GALECTIN THERAPEUTICS INC 0.2%
Value ($000) $1,083 Shares 312,000 Est. Cost $13.23 Unrealized -66.6%
MINERVA NEUROSCIENCES INC 0.2%
Value ($000) $1,054 Shares 175,000 Est. Cost $6.05 Unrealized
SCYNEXIS INC 0.2%
Value ($000) $998 Shares 100,000 Est. Cost $8.02 Unrealized
VCYT VERACYTE INC 0.1%
Value ($000) $968 Shares 100,200 Est. Cost $7.80 Unrealized 0.0%
AGILE THERAPEUTICS INC 0.1%
Value ($000) $921 Shares 150,000 Est. Cost $8.72 Unrealized
CURIS INC 0.1%
Value ($000) $900 Shares 600,000 Est. Cost $1.86 Unrealized
PTCT PTC THERAPEUTICS INC 0.1%
Value ($000) $518 Shares 10,000 Est. Cost $26.39 Unrealized +66.8%
EPIRUS BIOPHARAMCEUTICALS IN 0.1%
Value ($000) $425 Shares 75,000 Est. Cost $5.67 Unrealized
CELLECTAR BIOSCIENCES INC 0.1%
Value ($000) $424 Shares 530,000 Est. Cost $0.60 Unrealized
NEVRO CORP 0.1%
Value ($000) $387 Shares 10,000 Est. Cost $38.70 Unrealized
SAGE THERAPEUTICS INC 0.0%
Value ($000) $37 Shares 1,000 Est. Cost $31.50 Unrealized